![](/img/cover-not-exists.png)
Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients
Zinzani, P. L., Rossi, G., Franceschetti, S., Botto, B., Di Rocco, A., Cabras, M. G., Petti, M. C., Stefoni, V., Broccoli, A., Fanti, S., Pellegrini, C., Montini, G. C., Gandolfi, L., Derenzini, E., AVolume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-10-0162
Date:
August, 2010
File:
PDF, 202 KB
english, 2010